Acid-treated yeast cell wall as a binder displaying function of disintegrant

AAPS PharmSciTech

Volumn 4, Issue 3, 2003, Pages

  Ozeki, Tetsuya ^a   Katsuyama, Hideyo ^a   Yasuzawa, Yuriko ^a   Takashima, Yuuki ^a   Kasai, Takahide ^b   Eguchi, Takahiro ^b   Kakiuchi, Hisaya ^b   Yuasa, Hiroshi ^a   Okada, Hiroaki ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b KIRIN BREWERY CO LTD   (Japan)

Author keywords

Acid treated yeast cell wall; Binder; Disintegrant; Granulation; Pharmaceutical additive; Swelling

Indexed keywords

ACETYLSALICYLIC ACID; DISINTEGRATING AGENT; HYDROXYPROPYLCELLULOSE; POVIDONE; PULLULAN; ACID; EXCIPIENT; PHARMACEUTICAL VEHICLES AND ADDITIVES; WATER;

ARTICLE; CELL MEMBRANE FLUIDITY; CELL WALL; CONTROLLED STUDY; DRUG BINDING; DRUG GRANULATION; DRUG RELEASE; DRUG SOLUBILITY; PARTICLE SIZE; POWDER; SCANNING ELECTRON MICROSCOPY; TABLET COMPRESSION; TABLET DISINTEGRATION; TABLET DISINTEGRATION TIME; TABLET PROPERTY; TABLET SURFACE; TENSILE STRENGTH; WATER ABSORPTION; WATER PERMEABILITY; YEAST CELL; CHEMISTRY; DELAYED RELEASE FORMULATION; METABOLISM; SACCHAROMYCES CEREVISIAE; TABLET; TIME;

ACIDS; ASPIRIN; CELL WALL; DELAYED-ACTION PREPARATIONS; EXCIPIENTS; PARTICLE SIZE; PHARMACEUTIC AIDS; POWDERS; SACCHAROMYCES CEREVISIAE; TABLETS; TENSILE STRENGTH; TIME FACTORS; WATER;

EID: 23144440786     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt040341     Document Type: Article

References (25)

1. Kaneko K, Kanada K, Ouchi K, et al. Control of drug release from granules coated with sodium alginate and calcium lactate through insoluble gel formation. J Pharm Sci Technol. 1999;59:8-16.
2. Watanabe K, Yakou S, Takayama K, Machida Y, Nagai T. Drug release behaviors from hydrogel prepared with water soluble dietary fibers. J Pharm Sci Technol. 1991;51:29-35.
3. Ashford M, Fell J, Atwood D, Sharma H, Woodhead P. Studies on pectin formulation for colonic drug delivery. J Control Release. 1994;30:225-232.
4. Hou W, Miyazaki S, Takada M. Intragastric-floating and sustained-release tablets using chitosan and chitosan hydrochloride. J Pharm Sci Technol. 1991;51:93-99.
5. Kasai T, Eguchi T, Ishiwaki N, Kaneshige J, Ozeki T, Yuasa H. Application of acid-treated yeast cell wall (AYC) as a pharmaceutical additive, I: AYC as a novel coating material. Int J Pharm. 2000;204:53-59.
6. Yuasa H, Kaneshige J, Ozeki T, Kasai T, Eguchi T, Ishiwaki N. Application of acid-treated yeast cell wall (AYC) as a pharmaceutical additive, II: effects of curing on the medicine release from AYC-coated tablets. Int J Pharm. 2000;209:69-77.
7. Yuasa H, Kaneshige J, Ozeki T, Kasai T, Eguchi T, Ishiwaki N. Application of acid-treated yeast cell wall (AYC) as a pharmaceutical additive, III: AYC aqueous coating onto granules and film formation mechanism of AYC. Int J Pharm. 2002;237:15-22.
8. Yuasa H, Katsuyama H, Ozeki T, et al. Acid-treated yeast cell wall (AYC) as a novel binder. J Pharm Sci Technol. 2002;62:153-160.
9. Northcote DH, Horne RW. The chemical composition and structure of the yeast cell wall. Biochem J. 1952;51:232-236.
10. Fleet GH, Manners DH. Isolation and composition of an alkali-soluble glucan from the cell walls of Ssaccharomyces cerevisiae. J Gen Microbiol. 1976;94:180-192.
11. Lampen JO. External enzymes of yeast: their nature and formation. Antonie Van Leeuwenhoek. 1968;34:1-18.
12. Kidby DK, Davies R. Invertase and disulphide bridges in the yeast wall. J Gen Microbiol. 1970;61:327-333.
13. Joneja SK, Harcum WW, Skinner G, Barnum PE, Guo JH. Investigating the fundamental effects of binders on pharmaceutical tablet performance. Drug Dev Ind Pharm. 1999;25:1129-1135.
14. Salib NN, El-Gamal SA. Application of some polymers in the physicochemical design of tablet formulation. Pharmazie. 1976;31:718-721.
15. Kawaguchi T, Sunada H, Yonezawa Y, et al. Granulation of acetaminophen by a rotating fluidized-bed granulator. Pharm Dev Technol. 2000;5:141-151.
16. Lipps DM, Salr AM. Characterization of wet granulation process parameters using response surface methodology, I: top-spray fluidized bed. J Pharm Sci. 1994;83:937-947.
17. Thiel WJ, Nguyen LT. Fluidized bed granulation of an ordered powder mixture. J Pharm Pharmcol. 1982;34:692-699.
18. Chowhan ZY, Chow YP. Compression properties of granulations made with binders containing different moisture contents. J Pharm Sci. 1981;70:1134-1139.
19. Meshali M, El-banna HM, El-Sabbagh H. Use of a fractional factorial design to evaluate granulations prepared in a fluidized bed. Pharmazie. 1983;26:323-325.
20. Soyeux P, Delacourte A, Delie B, Lefevre P, Boniface B. Influence and optimisation of operating parameters with a new binder in wet granulation. Eur J Pharm Biopharm. 1998;46:95-103.
21. Gissinger D, Stamm A. A comparative evaluation of the properties of some tablet disintegrants. Drug Dev Ind Pharm. 1980;6:511-536.
22. Kanig JL, Rudunc EM. The mechanisms of disintegrant action. Pharm Technol. 1984;April:50-63.
23. Dumoulin Y, Clement P, Mateescu MA, Cartiler L. Cross-linked amylase as a binder/disintegrant in compressed tablets. S.T.P. Pharma Sci. 1994;4:329-335.
24. Collin-Beach DP, Hollenbeck RG. Determination of the energy of tablet formation during compression of selected pharmaceutical powders. Int J Pharm. 1983;17:313-324.
25. Christer N, Maria G. Studies on direct compression of tablets, XIII: The effect of some dry binders on the tablet strength of compounds with different fragmentation propensity. Int J Pharm. 1985;23:255-263.